04/12/2011
https://congress.gov...
"Do you have authority at FDA or at HHS to waive any of the requirements with regard to efficacy, good manufacturing practices, or safety, yes or no, in the event of shortage?"
"At the end of the day, American consumers and patients are facing 3 problems: 1) the drugs, they need to be available and affordable; 2) are there drugs they need safe; and 3) are they efficacious? Do..."
"I believe that agency has documented that fact over the course of 3 years and two administrations, one of each, Republican and Democratic."
"I hope that we don't take the failure, for whatever reason, of this project to mean that all renewable energy projects are bad investments."